Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/31740
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2023-03-27T05:16:48Z-
dc.date.available2023-03-27T05:16:48Z-
dc.date.issued2018-10-05-
dc.identifier.citationTai, P. vd. (2019). ''Outcomes of patients presenting with mild acute respiratory distress syndrome insights from the lung safe study''. Anesthesiology, 130(2), 263-283.en_US
dc.identifier.issn0003-3022-
dc.identifier.issn1528-1175-
dc.identifier.urihttps://doi.org/10.1097/ALN.0000000000002508-
dc.identifier.urihttps://pubs.asahq.org/anesthesiology/article/130/2/263/20088/Outcomes-of-Patients-Presenting-with-Mild-Acute-
dc.identifier.urihttp://hdl.handle.net/11452/31740-
dc.descriptionÇalışmada 868 yazar bulunmaktadır. Bu yazarlardan sadece Bursa Uludağ Üniversitesi mensuplarının girişleri yapılmıştır.tr_TR
dc.description.abstractBackground: Patients with initial mild acute respiratory distress syndrome are often underrecognized and mistakenly considered to have low disease severity and favorable outcomes. They represent a relatively poorly characterized population that was only classified as having acute respiratory distress syndrome in the most recent definition. Our primary objective was to describe the natural course and the factors associated with worsening and mortality in this population. Methods: This study analyzed patients from the international prospective Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE) who had initial mild acute respiratory distress syndrome in the first day of inclusion. This study defined three groups based on the evolution of severity in the first week: " worsening" if moderate or severe acute respiratory distress syndrome criteria were met, " persisting" if mild acute respiratory distress syndrome criteria were the most severe category, and " improving" if patients did not fulfill acute respiratory distress syndrome criteria any more from day 2. Results: Among 580 patients with initial mild acute respiratory distress syndrome, 18% (103 of 580) continuously improved, 36% (210 of 580) had persisting mild acute respiratory distress syndrome, and 46% (267 of 580) worsened in the first week after acute respiratory distress syndrome onset. Global in-hospital mortality was 30% (172 of 576; specifically 10% [10 of 101], 30% [63 of 210], and 37% [99 of 265] for patients with improving, persisting, and worsening acute respiratory distress syndrome, respectively), and the median (interquartile range) duration of mechanical ventilation was 7 (4, 14) days (specifically 3 [2, 5], 7 [4, 14], and 11 [6, 18] days for patients with improving, persisting, and worsening acute respiratory distress syndrome, respectively). Admissions for trauma or pneumonia, higher nonpulmonary sequential organ failure assessment score, lower partial pressure of alveolar oxygen/fraction of inspired oxygen, and higher peak inspiratory pressure were independently associated with worsening. Conclusions: Most patients with initial mild acute respiratory distress syndrome continue to fulfill acute respiratory distress syndrome criteria in the first week, and nearly half worsen in severity. Their mortality is high, particularly in patients with worsening acute respiratory distress syndrome, emphasizing the need for close attention to this patient population.en_US
dc.description.sponsorshipEuropean Society of Intensive Care Medicine (ESICM)en_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAtıf Gayri Ticari Türetilemez 4.0 Uluslararasıtr_TR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAnesthesiologyen_US
dc.subjectEnd-expiratory pressureen_US
dc.subjectIntensive-care unitsen_US
dc.subjectMechanical ventilationen_US
dc.subjectHospital mortalityen_US
dc.subjectSofa scoreen_US
dc.subjectInjuryen_US
dc.subjectArdsen_US
dc.subjectEpidemiologyen_US
dc.subjectSubphenotypesen_US
dc.subjectDefinitionsen_US
dc.titleOutcomes of patients presenting with mild acute respiratory distress syndrome insights from the lung safe Studyen_US
dc.typeArticleen_US
dc.identifier.wos000466747200013tr_TR
dc.identifier.scopus2-s2.0-85060572037tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Cerrahi Tıp Bilimleri/Anesteziyoloji ve Reanimasyon Anabilim Dalı.tr_TR
dc.identifier.startpage263tr_TR
dc.identifier.endpage283tr_TR
dc.identifier.volume130tr_TR
dc.identifier.issue2tr_TR
dc.relation.journalAnesthesiologyen_US
dc.contributor.buuauthorCeylan, İlkay-
dc.contributor.buuauthorGirgin, Nermin Kelebek-
dc.contributor.researcheridAAH-7250-2019tr_TR
dc.relation.collaborationYurt dışıtr_TR
dc.relation.collaborationSanayitr_TR
dc.relation.collaborationYurt içitr_TR
dc.identifier.pubmed30499850tr_TR
dc.subject.wosAnesthesiologyen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubMeden_US
dc.wos.quartileQ1en_US
dc.contributor.scopusid57200337923tr_TR
dc.contributor.scopusid55663009300tr_TR
dc.subject.scopusAdult Respiratory Distress Syndrome; Acute Lung Injury; Artificial Ventilationen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeAdult respiratory distress syndromeen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeArtificial ventilationen_US
dc.subject.emtreeBody weighten_US
dc.subject.emtreeChronic liver failureen_US
dc.subject.emtreeComorbidityen_US
dc.subject.emtreeDiabetes mellitusen_US
dc.subject.emtreeDisease courseen_US
dc.subject.emtreeDisease severityen_US
dc.subject.emtreeEvolutionen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeHospital mortalityen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeImmunosuppressive treatmenten_US
dc.subject.emtreeIntensive care uniten_US
dc.subject.emtreeLung alveolus oxygen tensionen_US
dc.subject.emtreeLung injuryen_US
dc.subject.emtreeMajor clinical studyen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMiddle ageden_US
dc.subject.emtreeObservational studyen_US
dc.subject.emtreePartial pressureen_US
dc.subject.emtreePneumoniaen_US
dc.subject.emtreePopulationen_US
dc.subject.emtreePositive end expiratory pressureen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeProspective studyen_US
dc.subject.emtreeRisk factoren_US
dc.subject.emtreeSequential organ failure assessment scoreen_US
dc.subject.emtreeSurvival rateen_US
dc.subject.emtreeTidal volumeen_US
dc.subject.emtreeTreatment durationen_US
dc.subject.emtreeTreatment outcomeen_US
dc.subject.emtreeVentilated patienten_US
Appears in Collections:PubMed
Scopus
Web of Science

Files in This Item:
File Description SizeFormat 
Ceylan_Girgin_2019.pdf558.62 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons